Product Images Xromi
View Photos of Packaging, Labels & Appearance
- Chemical Structure - xromi 01
- Picture of bottle and oral dispensing syringes - xromi 02
- Figure A - xromi 03
- Figure B - xromi 04
- Figure C - xromi 05
- Figure D - xromi 06
- Figure E - xromi 07
- Figure F - xromi 08
- Figure G - xromi 09
- Figure H - xromi 10
- Figure I - xromi 11
- Figure J - xromi 12
- XROMI Bottle Label - xromi bottle label
- XROMI Carton Label - xromi carton label
Product Label Images
The following 14 images provide visual information about the product associated with Xromi NDC 62484-0015 by Nova Laboratories, Ltd., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - xromi 01
Picture of bottle and oral dispensing syringes - xromi 02
This is information about a bottle adaptor used with two syringes - a white syringe for doses more than 3 mL and a red syringe for doses of 3 mL or less. The marking on the adaptor indicates the oral dosing levels of 12 mL and 3 mL.*
Figure A - xromi 03
Figure B - xromi 04
Figure C - xromi 05
Figure D - xromi 06
Figure E - xromi 07
Figure F - xromi 08
Figure G - xromi 09
Figure H - xromi 10
Figure I - xromi 11
Figure J - xromi 12
XROMI Bottle Label - xromi bottle label
The text provides essential information about a medication called "Xromi" (hydroxyurea) in oral solution form with a concentration of 100 mg/mL. It includes details such as inactive ingredients, manufacturer, distributor, dosage instructions, storage conditions, and precautions. The medication is indicated for rare diseases and comes in 180 mL bottles. It is necessary to refrigerate the medication and not shake it before use. Additionally, the accompanying Medication Guide should be provided to each patient, and any unused portion should be discarded after 12 weeks from the first opening.*
XROMI Carton Label - xromi carton label
This is a description for Xromi, an oral solution containing 100 mg/mL of hydroxyurea. It is recommended for oral use only, with a warning that it is a hazardous drug and should not be shaken. The product is manufactured by Nova Laboratories Ltd in the United Kingdom and is intended for Rare Disease Therapeutics, Inc. in Tennessee. The solution comes in a 150 mL glass bottle and includes bottle adapters and oral dosing syringes. It also contains inactive ingredients such as methyl parahydroxybenzoate, purified water, and strawberry flavor. The Braille information provided on the packaging includes warnings and dosage instructions for patient safety.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
